A detailed history of Parallel Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, Parallel Advisors, LLC holds 13,524 shares of DHR stock, worth $3.28 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
13,524
Previous 13,079 3.4%
Holding current value
$3.28 Million
Previous $3.27 Million 3.43%
% of portfolio
0.09%
Previous 0.09%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$235.51 - $267.98 $104,801 - $119,251
445 Added 3.4%
13,524 $3.38 Million
Q1 2024

May 06, 2024

BUY
$224.58 - $256.19 $399,527 - $455,762
1,779 Added 15.74%
13,079 $3.27 Million
Q4 2023

Feb 09, 2024

SELL
$185.1 - $233.13 $192,689 - $242,688
-1,041 Reduced 8.44%
11,300 $2.61 Million
Q3 2023

May 20, 2024

BUY
$233.08 - $265.59 $117,705 - $134,122
505 Added 4.27%
12,341 $3.06 Million
Q3 2023

Nov 13, 2023

BUY
$233.08 - $265.59 $117,705 - $134,122
505 Added 4.27%
12,341 $3.06 Million
Q2 2023

May 20, 2024

SELL
$224.99 - $256.14 $101,245 - $115,263
-450 Reduced 3.66%
11,836 $2.84 Million
Q2 2023

Aug 04, 2023

SELL
$224.99 - $256.14 $101,245 - $115,263
-450 Reduced 3.66%
11,836 $2.84 Million
Q1 2023

May 20, 2024

SELL
$239.75 - $277.0 $190,121 - $219,661
-793 Reduced 6.06%
12,286 $3.1 Million
Q1 2023

Apr 25, 2023

BUY
$239.75 - $277.0 $96,859 - $111,908
404 Added 3.4%
12,286 $3.1 Million
Q4 2022

Feb 03, 2023

SELL
$241.42 - $282.29 $152,094 - $177,842
-630 Reduced 5.04%
11,882 $3.15 Million
Q3 2022

Nov 10, 2022

BUY
$247.06 - $1507.4 $78,812 - $480,860
319 Added 2.62%
12,512 $3.23 Million
Q2 2022

Aug 01, 2022

SELL
$237.11 - $299.66 $147,008 - $185,789
-620 Reduced 4.84%
12,193 $3.09 Million
Q1 2022

Apr 28, 2022

BUY
$257.27 - $315.76 $74,608 - $91,570
290 Added 2.32%
12,813 $3.81 Million
Q4 2021

Jan 20, 2022

BUY
$292.08 - $329.01 $144,287 - $162,530
494 Added 4.11%
12,523 $4.12 Million
Q3 2021

Nov 02, 2021

SELL
$272.21 - $332.43 $16,060 - $19,613
-59 Reduced 0.49%
12,029 $3.66 Million
Q2 2021

Aug 06, 2021

BUY
$225.08 - $271.69 $31,736 - $38,308
141 Added 1.18%
12,088 $3.24 Million
Q1 2021

Apr 23, 2021

BUY
$212.38 - $245.9 $202,398 - $234,342
953 Added 8.67%
11,947 $2.69 Million
Q4 2020

Feb 02, 2021

BUY
$212.5 - $245.46 $52,912 - $61,119
249 Added 2.32%
10,994 $2.44 Million
Q3 2020

Oct 27, 2020

BUY
$177.16 - $215.33 $62,360 - $75,796
352 Added 3.39%
10,745 $2.31 Million
Q2 2020

Jul 16, 2020

SELL
$128.7 - $176.83 $47,747 - $65,603
-371 Reduced 3.45%
10,393 $1.84 Million
Q1 2020

Apr 27, 2020

BUY
$121.39 - $169.05 $223,357 - $311,052
1,840 Added 20.62%
10,764 $1.49 Million
Q4 2019

Jan 30, 2020

SELL
$133.47 - $153.48 $4,938 - $5,678
-37 Reduced 0.41%
8,924 $1.37 Million
Q3 2019

Nov 01, 2019

BUY
$135.4 - $146.47 $53,889 - $58,295
398 Added 4.65%
8,961 $1.29 Million
Q2 2019

Aug 05, 2019

BUY
$124.88 - $143.73 $27,598 - $31,764
221 Added 2.65%
8,563 $1.22 Million
Q1 2019

May 01, 2019

BUY
$97.62 - $132.29 $70,286 - $95,248
720 Added 9.45%
8,342 $1.1 Million
Q4 2018

Feb 05, 2019

SELL
$94.85 - $109.54 $5,691 - $6,572
-60 Reduced 0.78%
7,622 $786,000
Q3 2018

Nov 01, 2018

BUY
$98.13 - $108.9 $55,149 - $61,201
562 Added 7.89%
7,682 $835,000
Q2 2018

Jul 30, 2018

BUY
$96.1 - $103.24 $41,323 - $44,393
430 Added 6.43%
7,120 $702,000
Q1 2018

May 08, 2018

SELL
$92.16 - $103.8 $3,225 - $3,633
-35 Reduced 0.52%
6,690 $655,000
Q4 2017

Feb 13, 2018

SELL
$85.26 - $94.62 $12,789 - $14,193
-150 Reduced 2.18%
6,725 $624,000
Q3 2017

Nov 15, 2017

BUY
$79.29 - $88.45 $545,118 - $608,093
6,875 New
6,875 $642,000
Q3 2017

Nov 14, 2017

SELL
$79.29 - $88.45 $562,166 - $627,110
-7,090 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
7,090
7,090 $578,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.